Aristides Capital LLC closes position in NLTX / Neoleukin Therapeutics, Inc
Fintel, 15 May 2020
Aristides Capital LLC has filed a 13F-HR form disclosing ownership of 0 shares of Neoleukin Therapeutics, Inc. (US:NLTX) with total holdings valued at $0 USD as of 2020-03-31. Aristides Capital LLC had filed a previous 13F-HR on 2020-02-13 disclosing 13,900 shares of Neoleukin Therapeutics, Inc. at a value of $171,000 USD. This represents a change in shares of -100.00 percent and a change in value of -100.00 percent during the quarter. Other investors with closed positions include Visium Asset Management, LP, Great Point Partners Llc, Perceptive Advisors Llc, Acuta Capital Partners, Llc, and Nomura Asset Management Co Ltd.
